These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 4086902)

  • 1. [On the results of hydatidiform mole managed by Niigata method].
    Hando T; Kodama S; Takeuchi S
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Dec; 37(12):2722-30. PubMed ID: 4086902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [On the follow up period of postmolar patient (author's transl)].
    Hando T; Maruyama S; Watanabe S; Hirogami T; Obata N; Kanazawa K; Takeuchi S
    Nihon Sanka Fujinka Gakkai Zasshi; 1982 Mar; 34(3):287-91. PubMed ID: 7069243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Studies on the viability of trophoblast after termination of various kinds of pregnancies (author's transl)].
    Kanda K
    Nihon Sanka Fujinka Gakkai Zasshi; 1980 Oct; 32(10):1575-82. PubMed ID: 6263995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistent trophoblast disease following partial molar pregnancy.
    Wielsma S; Kerkmeijer L; Bekkers R; Pyman J; Tan J; Quinn M
    Aust N Z J Obstet Gynaecol; 2006 Apr; 46(2):119-23. PubMed ID: 16638033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The excretion of chorionic gonadetropin in 55 cases of hydatidiform mole (author's transl)].
    Lichtenegger W; Weiss PA
    Geburtshilfe Frauenheilkd; 1977 Apr; 37(4):334-7. PubMed ID: 192629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study on follow-up procedure for postmolar patients].
    Endo N; Kobayashi O; Takamizawa H
    Nihon Sanka Fujinka Gakkai Zasshi; 1984 Apr; 36(4):531-8. PubMed ID: 6715935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Use of sulprostone in the evacuation of molar pregnancies].
    Pinet C; Colau JC
    Rev Fr Gynecol Obstet; 1991 Jan; 86(1):53-5. PubMed ID: 2068488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human chorionic gonadotropin and its subunits in hydatidiform mole and choriocarcinoma.
    Dawood MY; Saxena BB; Landesman R
    Obstet Gynecol; 1977 Aug; 50(2):172-81. PubMed ID: 195242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human chorionic gonadotrophin regression rate as a predictive factor of postmolar gestational trophoblastic neoplasm in high-risk hydatidiform mole: a case-control study.
    Kim BW; Cho H; Kim H; Nam EJ; Kim SW; Kim S; Kim YT; Kim JH
    Eur J Obstet Gynecol Reprod Biol; 2012 Jan; 160(1):100-5. PubMed ID: 22055909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prevention of the malignant form of trophoblastic disease after a hydatidiform mole: systematic or selective chemotherapy].
    Delvoye P; Robyn C
    J Gynecol Obstet Biol Reprod (Paris); 1975 Mar; 4(2):267-93. PubMed ID: 181422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gestational trophoblastic diseases - clinical guidelines for diagnosis, treatment, follow-up, and counselling.
    Niemann I; Vejerslev LO; Frøding L; Blaakær J; Maroun LL; Hansen ES; Grove A; Lund H; Havsteen H; Sunde L
    Dan Med J; 2015 Nov; 62(11):A5082. PubMed ID: 26522484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistence of gestational trophoblastic disease for longer than 1 year following evacuation of hydatidiform mole.
    Elmer DB; Granai CO; Ball HG; Curry SL
    Obstet Gynecol; 1993 May; 81(5 ( Pt 2)):888-90. PubMed ID: 7682320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma human chorionic gonadotropin disappearance in hydatidiform mole: a central registry report from the Netherlands.
    Franke HR; Risse EK; Kenemans P; Houx PC; Stolk JG; Vooijs GP
    Obstet Gynecol; 1983 Oct; 62(4):467-73. PubMed ID: 6888825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Choriocarcinoma following ovarian hydatidiform mole: a case report.
    Joneborg U; Papadogiannakis N; Lindell G; Marions L
    J Reprod Med; 2011; 56(11-12):511-4. PubMed ID: 22195336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Partial hydatidiform mole with false-negative urine human chorionic gonadatropin test in the emergency department.
    Mundangepfupfu T; Waseem M
    J Emerg Med; 2014 Mar; 46(3):348-50. PubMed ID: 24188605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum SP1, hPL and beta-hCG levels in trophoblastic diseases.
    Zhang WY; Yen GL
    Chin Med J (Engl); 1991 Dec; 104(12):995-8. PubMed ID: 1723674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Role of hysteroscopy in diagnosis and management of trophoblastic disease].
    Suzuki A; Kawaguchi K; Konishi I; Ida K; Fujii S; Matsuura S
    Nihon Sanka Fujinka Gakkai Zasshi; 1984 Feb; 36(2):255-60. PubMed ID: 6321615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurement of CA-125 in trophoblastic disease.
    Kohorn EI
    Gynecol Oncol; 2000 Jul; 78(1):39-42. PubMed ID: 10873407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [On interrupted postmolar choriocarcinoma].
    Hando T; Kodama S; Takeuchi S; Goto S
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Oct; 37(10):2019-22. PubMed ID: 4078405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complete hydatidiform mole in women aged 40 to 49 years.
    Elias KM; Shoni M; Bernstein M; Goldstein DP; Berkowitz RS
    J Reprod Med; 2012; 57(5-6):254-8. PubMed ID: 22696822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.